Teleflex (TFX) Announces 510(k) Clearance and Global Launch of Twin-Pass® Torque Dual Access Catheter
March 14 2017 - 6:45AM
Business Wire
Dual access catheter enables a 0.014" guidewire
to remain in place while delivering contrast, medication, or a
second 0.014" guidewire – new Torque version builds on Vascular
Solutions’ long-standing Twin-Pass Catheter platform with enhanced
torque response and precise angle alignment into side branch
vessels
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, has announced
510(k) clearance by the Food and Drug Administration and both U.S.
and international commercial launch of the Twin-Pass Torque Dual
Access Catheter.
Twin-Pass Dual Access Catheters contain both a rapid-exchange
(RX) lumen and an over-the-wire (OTW) lumen. With a 0.014"
guidewire deployed through the RX lumen into the main branch, the
OTW lumen can be used for guidewire exchange, subsequent delivery
of a second guidewire into a side branch, or fluid injection to a
desired distal vessel segment.
“The Twin-Pass Torque Catheter builds on Vascular Solutions’
12-year legacy with our original Twin-Pass Dual Access Catheter,
that has been gaining in popularity among interventionalists as the
number of complex procedures continues to grow rapidly,” said Chad
Kugler, Vice President of Research & Development of the
Vascular Solutions division of Teleflex. “This newly-launched
version is designed for procedures that call for the delivery of
two interventional guidewires from a single catheter in clinical
situations where catheter delivery and torsional control are
paramount. The new version of the Twin-Pass will allow the
physician to achieve precise side-branch access, an important
capability in many complex interventions.”
The Twin-Pass Torque Catheter is intended to access discrete
regions of the coronary and/or peripheral vasculature, to
facilitate placement and exchange of guidewires, and to
subselectively infuse/deliver diagnostic and therapeutic
agents.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch, Twin-Pass, and Weck are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates, in the U.S.
and/or other countries.
© 2017 Teleflex Incorporated. All rights reserved. MC-003134
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170314005155/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024